Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Article in Russian | MEDLINE | ID: mdl-1908166

ABSTRACT

The method for the determination of bacterial antibodies to group B meningococci was worked out. The method was used for the determination of antibodies to group B meningococcal vaccine produced in the USSR. The dynamic study of antibodies to protein, polysaccharide and lipopolysaccharide antigens of group B meningococci was made by the method of the enzyme immunoassay (EIA), and the safety of the vaccine was studied by the determination of autoantibodies active against brain tissue antigens. The data thus obtained were indicative of the immunological activity of group B protein-polysaccharide vaccines, manifested by the capacity for stimulating bactericidal antibodies whose level increased 8- to 10-fold after the immunization of monkeys in 2 and 3 injections. Similarity in the dynamics of the formation of bacteriolysins and antibodies to protein antigen, as determined in EIA, was noted. The vaccine was found to stimulate no cytotoxic anticerebral antibodies in the glia migration test, which was indicative of the safety of group B meningococcal vaccine.


Subject(s)
Bacterial Vaccines/immunology , Neisseria meningitidis/immunology , Animals , Antibodies, Bacterial/blood , Autoantibodies/blood , Bacterial Vaccines/adverse effects , Brain/immunology , Drug Evaluation, Preclinical , Enzyme-Linked Immunosorbent Assay/methods , Immunization/methods , Lipopolysaccharides/immunology , Macaca mulatta , Neuroglia/immunology , Polysaccharides, Bacterial/immunology , Time Factors
2.
Zh Mikrobiol Epidemiol Immunobiol ; (11): 50-6, 1990 Nov.
Article in Russian | MEDLINE | ID: mdl-2129073

ABSTRACT

The protein-polysaccharide complex, isolated from group B N. meningitidis, is a variant of vaccine for the prophylaxis of group B N. meningitidis infection. In this investigation the influence of the complex of the physical properties of aluminium hydroxide gels, the amount of gel, pH and the duration of sorption on the process of sorption has been studied. Aluminium hydroxide has been shown to produce a stimulating effect on the response of mice to the polysaccharide and protein contained in the complex after immunization made in two injections. Gels with a smaller particle size have been found to possess greater adjuvant activity, as well as greater absorbing activity. The immunological activity of the complex, adsorbed ex tempore, has proved to be no different from that of the complex adsorbed in an hour.


Subject(s)
Bacterial Proteins/isolation & purification , Lipopolysaccharides/isolation & purification , Neisseria meningitidis , Aluminum Hydroxide , Animals , Antibodies, Bacterial/blood , Bacterial Proteins/immunology , Bacterial Vaccines/immunology , Bacterial Vaccines/isolation & purification , Chemical Phenomena , Chemistry, Physical , Gels , Hydrogen-Ion Concentration , Immunization , Immunosorbent Techniques , Lipopolysaccharides/immunology , Mice , Mice, Inbred CBA , Neisseria meningitidis/classification , Neisseria meningitidis/immunology , Particle Size , Serotyping , Time Factors
3.
Zh Mikrobiol Epidemiol Immunobiol ; (10): 84-9, 1990 Oct.
Article in Russian | MEDLINE | ID: mdl-1963725

ABSTRACT

The comparative study of two group B meningococcal vaccines manufactured in the USSR and in Cuba was made. The vaccine manufactured in the USSR contained the noncovalent compound of group B Neisseria meningitidis polysaccharide and outer membrane protein, and the Cuban vaccine contained group B N. meningitidis outer membrane proteins and group C N. meningitidis polysaccharide. The data obtained in this study indicated that both vaccines possessed immunological potency evaluated according to their capacity to stimulate the formation of bactericidal antibodies, whose level was found to increase eightfold after the immunization of monkeys in two injections. Besides, group B meningococcal vaccines did not induce the suppression of nonspecific protective activity characteristics of the body and did not stimulate the formation of autoantibodies to brain and liver tissues, which was indicative of the safety of these vaccines.


Subject(s)
Bacterial Vaccines/immunology , Neisseria meningitidis/immunology , Animals , Autoantibodies/analysis , Bacterial Outer Membrane Proteins/immunology , Bacterial Vaccines/toxicity , Blood Bactericidal Activity/drug effects , Blood Bactericidal Activity/immunology , Brain/immunology , Cuba , Drug Evaluation, Preclinical , Immunity, Innate/drug effects , Immunity, Innate/immunology , Immunization , Macaca mulatta , Neutrophils/drug effects , Neutrophils/immunology , Peroxidase/blood , Polysaccharides, Bacterial/immunology , Time Factors , USSR
4.
Article in Russian | MEDLINE | ID: mdl-3140546

ABSTRACT

The hybridization of myeloma cells NP with lymphocytes of mice, immunized with protein isolated from Neisseria meningitidis strain Bc5 in a single injection into the spleen 3 days prior to fusion, made it possible to obtain 25-72% of hybridomas secreting antibodies to meningococcal antigens. The treatment of immune lymphocytes from these mice with the total preparations of nucleic acids, isolated by the phenol-detergent method from mouse myeloma cells NP and NS/0, induced an increase in the proliferative activity of lymphocytes; in some microcultures multilayer cell growth was observed on the bottom of the wells, whereas in the control microcultures such growth was absent. No synthesis of specific antibodies was detected in the cultures of lymphocytes whose proliferation was stimulated with nucleic acids.


Subject(s)
B-Lymphocytes/cytology , Animals , Antibodies, Bacterial/biosynthesis , Antibodies, Monoclonal/biosynthesis , Antibody Specificity , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , Cell Division/drug effects , Cell Line , Cell Separation/methods , Hybridomas/cytology , Hybridomas/drug effects , Hybridomas/immunology , Immunization , Mice , Mice, Inbred BALB C , Multiple Myeloma/immunology , Neisseria meningitidis/immunology , Nucleic Acids/pharmacology , Spleen/cytology , Spleen/drug effects , Spleen/immunology , Time Factors
5.
Article in Russian | MEDLINE | ID: mdl-3551420

ABSTRACT

The tumorigenic capacity of mouse B-cell hybridomas in both cloned and primary cultures was studied. The cells were selected for inoculation from 24-well plates and introduced into the spleen of syngeneic mice. The cells took in 50% of the animals. The cells of hybridoma tumors induced as the result of intrasplenic inoculation, when subcultured in the second passage following the standard scheme, i.e. inoculated intraperitoneally in a dose of 1 X 10(7) cells into mice previously treated with vaseline oil or pristane, produced tumors in 100% of the animals.


Subject(s)
B-Lymphocytes/cytology , Hybridomas/cytology , Spleen/cytology , Animals , Antibodies, Monoclonal/analysis , Cytological Techniques , Dose-Response Relationship, Immunologic , Hybridomas/immunology , Hybridomas/transplantation , Immunization/methods , Mice , Mice, Inbred A , Mice, Inbred BALB C , Multiple Myeloma/pathology , Neoplasm Transplantation , Neoplasms, Experimental/etiology , Neoplasms, Experimental/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...